Achieve Life Sciences
ACHV
ACHV
35 hedge funds and large institutions have $13.4M invested in Achieve Life Sciences in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
56% less call options, than puts
Call options by funds: $111K | Put options by funds: $252K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
35
Holding in Top 10
–
Calls
$111K
Puts
$252K
Top Buyers
| 1 | +$102K | |
| 2 | +$97.4K | |
| 3 | +$71K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$69.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$48.5K |
Top Sellers
| 1 | -$1.12M | |
| 2 | -$477K | |
| 3 | -$153K | |
| 4 |
Walleye Capital
New York
|
-$109K |
| 5 |
BFA
Beaumont Financial Advisors
Needham,
Massachusetts
|
-$81.6K |